Dynamic Technology Lab Private LTD Rocket Pharmaceuticals, Inc. Transaction History
Dynamic Technology Lab Private LTD
- $550 Million
- Q3 2025
A detailed history of Dynamic Technology Lab Private LTD transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 30,760 shares of RCKT stock, worth $93,818. This represents 0.02% of its overall portfolio holdings.
Number of Shares
30,760
Previous 28,370
8.42%
Holding current value
$93,818
Previous $189,000
47.09%
% of portfolio
0.02%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding RCKT
# of Institutions
194Shares Held
96.4MCall Options Held
563KPut Options Held
418K-
Rtw Investments, LP New York, NY17.7MShares$53.9 Million0.77% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.47MShares$25.8 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.89MShares$21 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18.9 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA3.9MShares$11.9 Million2.3% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $231M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...